TELCON RF PHARMACEUTICAL. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26,125	3,306	8,519	9,734	23,195
Short-Term Investments	-	731	2,000	-	-
Trading Asset Securities	6,000	6,000	-	-	-
Cash & Short-Term Investments	32,125	10,037	10,519	9,734	23,195
Cash Growth	220.07%	-4.58%	8.07%	-58.04%	-6.21%
Accounts Receivable	8,100	8,738	8,991	6,139	9,479
Other Receivables	870.46	242.79	177.97	267.88	224.23
Receivables	17,049	9,060	16,222	6,439	9,703
Inventory	5,123	4,956	5,003	4,622	4,303
Prepaid Expenses	265.68	223.42	83.2	73.74	98.87
Other Current Assets	3,172	1,735	1,161	2,258	55.98
Total Current Assets	57,735	26,011	32,989	23,127	37,357
Property, Plant & Equipment	9,877	11,180	8,468	8,038	9,320
Long-Term Investments	70,213	94,886	74,800	63,375	90,287
Other Intangible Assets	16,234	18,738	21,338	23,881	30,201
Long-Term Accounts Receivable	-	-	-	-	-0
Other Long-Term Assets	2,551	2,703	2,774	799.52	864.83
Total Assets	156,668	153,588	140,415	119,255	168,030
Accounts Payable	3,142	2,818	2,581	2,668	2,630
Accrued Expenses	1,173	899.94	697.9	720.39	901.94
Short-Term Debt	32,308	54,663	26,443	28,853	53,991
Current Portion of Long-Term Debt	-0	0	0	0	0
Current Portion of Leases	527.59	437.95	577.16	694.1	644.11
Other Current Liabilities	9,109	10,901	4,625	1,394	1,946
Total Current Liabilities	46,259	69,720	34,924	34,329	60,113
Long-Term Leases	1,433	589.71	403.02	727.85	1,301
Other Long-Term Liabilities	157.61	143.39	143.41	62.77	7.91
Total Liabilities	47,850	70,453	35,470	35,120	61,422
Common Stock	68,524	12,025	11,599	10,860	9,991
Additional Paid-In Capital	229,052	245,985	243,907	238,108	216,003
Retained Earnings	-191,918	-180,462	-154,142	-168,048	-126,310
Treasury Stock	-56.04	-56.04	-	-	-
Comprehensive Income & Other	2,899	5,337	3,094	3,203	6,896
Total Common Equity	108,501	82,830	104,459	84,123	106,580
Minority Interest	317.35	305.35	485.46	12.26	27.59
Shareholders' Equity	108,818	83,135	104,945	84,135	106,608
Total Liabilities & Equity	156,668	153,588	140,415	119,255	168,030
Total Debt	34,268	55,691	27,423	30,275	55,936
Net Cash (Debt)	-2,143	-45,654	-16,904	-20,542	-32,741
Net Cash Per Share	-44.72	-1287.06	-376.79	-498.59	-1242.32
Filing Date Shares Outstanding	132.11	36.05	34.8	32.58	29.97
Total Common Shares Outstanding	132.11	36.08	34.8	32.58	29.97
Working Capital	11,475	-43,709	-1,935	-11,202	-22,756
Book Value Per Share	821.26	2296.03	3001.83	2581.94	3555.91
Tangible Book Value	92,267	64,092	83,121	60,242	76,379
Tangible Book Value Per Share	698.38	1776.62	2388.64	1848.97	2548.30
Land	827.37	827.37	827.37	827.37	827.37
Buildings	5,407	5,576	5,281	4,974	4,867
Machinery	11,858	10,720	8,702	8,016	7,927
Construction In Progress	77.6	1,027	-	325	316

Source: S&P Global Market Intelligence. Standard template. Financial Sources.